alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
FORM OF OFFICER'S CERTIFICATE
                             PURSUANT TO SECTION 302

                                  CERTIFICATION

      I, Peter J. Hamilton, certify that:

      1. I have reviewed this annual report on Form 10-KSB of ActiveCore
Technologies Corporation;

      2. Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this annual
report;

      3. Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

      4. I am responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the
registrant and we have:

            a) designed such disclosure controls and procedures to ensure that
material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this annual report is being prepared;

            b) evaluated the effectiveness of the registrant's disclosure
controls and procedures and presented in this report my conclusion about the
effectiveness of the disclosure controls and procedures as of the end of the
period covered by this report based on such evaluation;

            c) presented in this annual report our conclusions about the
effectiveness of the disclosure controls and procedures based on our evaluation
as of the Evaluation Date;

      5. I have disclosed, based on our most recent evaluation, to the
registrant's auditors and the audit committee of registrant's board of directors
(or persons performing the equivalent function):

            a) all significant deficiencies in the design or operation of
internal controls which could adversely affect the registrant's ability to
record, process, summarize and report financial data and have identified for the
registrant's auditors any material weaknesses in internal controls; and

            b) any fraud, whether or not material, that involves management or
other employees who have a significant role in the registrant's internal
controls; and

      6. I have indicated in this annual report any change in the registrant's
internal control over financial reporting that ocurred during the registrant's
fourth fiscal quarter that has materially affected, or is reasonably likely to
materially affect, the registrant's internal control over financial reporting.

Date: May , 2005                      By: /s/
                                          -------------------------------------
                                          Peter J. Hamilton
                                          President and Chief Executive Officer
                                          Acting Chief Financial Officer
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                       1,251,849
<SECURITIES>                                         0
<RECEIVABLES>                                  582,508
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             2,168,071
<PP&E>                                               0 
<DEPRECIATION>                                   8,479
<TOTAL-ASSETS>                               2,513,227
<CURRENT-LIABILITIES>                          255,503
<BONDS>                                      2,217,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         1,000
<OTHER-SE>                                      39,724
<TOTAL-LIABILITY-AND-EQUITY>                 2,513,227
<SALES>                                              0
<TOTAL-REVENUES>                                41,977
<CGS>                                                0
<TOTAL-COSTS>                                   41,253
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              28,085
<INCOME-PRETAX>                                    724
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       724
<EPS-PRIMARY>                                      .72
<EPS-DILUTED>                                      .72
        

</TABLE>
Filed 9/24/15 P. v. Landaverde CA2/1

NOT TO BE PUBLISHED IN THE OFFICIAL REPORTS

California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for 

publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication 

or ordered published for purposes of rule 8.1115.

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

SECOND APPELLATE DISTRICT

DIVISION ONE

THE PEOPLE,

Plaintiff and Respondent,

v.

ANTONIO LANDAVERDE,

Defendant and Appellant.

 B261553

 (Los Angeles County

 Super. Ct. No. BA426685)

APPEAL from a judgment of the Superior Court of Los Angeles County. 

David V. Herriford, Judge. Affirmed.

______

Athena Shudde, under appointment by the Court of Appeal, for Defendant and 

Appellant.

No appearance for Plaintiff and Respondent.

______
2

An information, filed on August 5, 2014 and later amended by interlineation, 

charged Antonio Landaverde with two counts of resisting an executive officer

(Pen. Code, § 69). The jury found Landaverde guilty of both counts. The trial court 

suspended imposition of sentence and placed Landaverde on formal probation for 

36 months. Landaverde appealed. 

We appointed counsel to represent Landaverde in the matter. After examining 

the record, counsel filed a Wende brief raising no issues on appeal and requesting that 

we independently review the record. (People v. Wende (1979) 25 Cal.3d 436.) On 

June 11, 2015, we sent a letter to Landaverde and to counsel. In the letter, we directed 

counsel to immediately send the record on this appeal and a copy of the Wende brief to 

Landaverde and informed Landaverde that he had 30 days to submit by letter or brief any 

ground of appeal, contention or argument he wished us to consider. We did not receive a 

response from him.

We have reviewed the entire record on appeal. Evidence shows that Landaverde 

grabbed the open end of a handcuff, swung at a police officer and reached for the 

officer’s gun during his detention in response to a call of shots fired at an apartment. 

At the time, the officer believed that Landaverde matched the description of the suspect 

provided in the dispatch call. Landaverde also struggled with the officer’s partner, who 

attempted to assist with the detention based on Landaverde’s conduct. This evidence 

sufficiently supports his conviction of two counts of resisting an executive officer. 

(People v. Johnson (1980) 26 Cal.3d 557, 578 [substantial evidence is that which is 

“reasonable, credible, and of solid value—such that a reasonable trier of fact could find 

the defendant guilty beyond a reasonable doubt”].) We are satisfied that Landaverde’s 

counsel has fully complied with his responsibilities and that no arguable appellate issue 

exists. (People v. Wende, supra, 25 Cal.3d at p. 441; People v. Kelly (2006) 40 Cal.4th 

106, 110.)
3

DISPOSITION

The judgment is affirmed.

NOT TO BE PUBLISHED.

ROTHSCHILD, P. J.

We concur:

CHANEY, J.

LUI, J.
## IN THE UNI TED STAT ES COURT OFAPPEALS FOR THE FIF TH CIRCU IT

No. 12-50719 Summary Calendar
STEPHEN A. MAYBANK, Plaintiff-Appellant v. JOHN M. MCHUGH, Secretary, Department of the Army Defendant-Appellee

Appeal from the United States District Court for the Western District of Texas USDC No. 5:11-CV-508
Before REAVLEY, JOLLY, and DAVIS, Circuit Judges. PER CURIAM: * 

### T hi s c o urt has reviewed the record and Plaintiff’s complaints o f discrimination and illegal retaliati o n , a n d w e agree with the rulings of Judge Rodriguez made in his order dated, June 18, 2012. Th e j u d g m e nt must be affirmed. AFFIRMED. U n i te d S ta te s C o u rt o f A p p ea l s F i ft h C i rc u i t 

## F I L E D Janu ary18 , 20 13 Lyle W . Cayce Clerk

Pursua nt to 5 T H C IR
. R. 47.5 , the cour t hasd ete rm inedt hat this op inion s houldnot * be publ ish ed and is not pr ece dent excep t unde r the lim ite d cir cum st ance s se t forth in 5 T H C IR
. R. 47.5 .4. 

### Case: 12-50719 Document: 00512118525 Page: 1 Date Filed: 01/18/2013
I 

115TH CONGRESS 

2D SESSION H. R. 5162 

To amend the Consumer Product Safety Act to remove the exclusion of 

pistols, revolvers, and other firearms from the definition of consumer 

product in order to permit the issuance of safety standards for such 

articles by the Consumer Product Safety Commission. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 5, 2018 

Ms. KELLY of Illinois (for herself, Mr. MCGOVERN, Mr. VARGAS, Mr. LYNCH, 

Mr. CUMMINGS, Ms. CLARK of Massachusetts, Mr. MOULTON, Mr. RYAN

of Ohio, Mrs. WATSON COLEMAN, Mrs. CAROLYN B. MALONEY of New 

York, Mr. YARMUTH, Mr. GUTIE ́RREZ, Mr. SCHIFF, Mr. CA ́RDENAS, Mr. 

DESAULNIER, Mr. MEEKS, Ms. MCCOLLUM, Ms. WASSERMAN SCHULTZ, 

Mr. KEATING, Mr. DANNY K. DAVIS of Illinois, Ms. PLASKETT, and Ms. 

BROWNLEY of California) introduced the following bill; which was referred to the Committee on Energy and Commerce 

A BILL 

To amend the Consumer Product Safety Act to remove the 

exclusion of pistols, revolvers, and other firearms from 

the definition of consumer product in order to permit 

the issuance of safety standards for such articles by 

the Consumer Product Safety Commission. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


amozie on DSK30RV082PROD with BILLS
2 

•HR 5162 IH

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Firearm Safety Act 

3 of 2018’’. 

4 SEC. 2. REMOVAL OF EXCLUSION OF FIREARMS FROM THE 

5 DEFINITION OF CONSUMER PRODUCT. 

6 Section 3(a)(5) of the Consumer Product Safety Act 

7 (15 U.S.C. 2052(a)(5)) is amended by striking subpara8 graph (E) and redesignating subparagraphs (F) through 

9 (I) as subparagraphs (E) through (H), respectively. 

Æ 


amozie on DSK30RV082PROD with BILLS
<PAGE>
                                                                    Exhibit 23.2


                       CONSENT OF INDEPENDENT ACCOUNTANTS



We hereby consent to the incorporation by reference in the Registration
Statements on Form S-3 (File No. 33-85896) and Form S-8 (File No. 33-78592, File
No. 333-69913, File No. 333-79445, File No. 333-37912, and File No. 333-79503)
of D&E Communications, Inc. of our report dated February 25, 2002, on our audits
of the consolidated financial statements of EuroTel L.L.C. which appears in this
Form 10-K.


PricewaterhouseCoopers SpA

/s/ Nicola DeBenedetto
Nicola DiBenedetto
(Partner)

Rome, Italy

March 28, 2003
Exhibit 32.1



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of Colony RIH Holdings, Inc. and Resorts International Hotel and Casino, Inc. (the Company) on Form
10-Q for the period ending June 30, 2004 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Audrey S. Oswell, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



| | 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | -- | ---------------------------------------------------------------------------------------------------------------------



| | 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                                     
|-------------------------------------
|/s/ AUDREY S. OSWELL                 
|Audrey S. Oswell                     
|President and Chief Executive Officer



August 13, 2004
**EXHIBIT 31.1**

 

**CERTIFICATION OF**

**CHIEF EXECUTIVE OFFICER**

**OF MAX RE CAPITAL LTD.**

 

I, Robert J. Cooney, the Chief Executive Officer of Max Re Capital Ltd., certify that: 

 

1. I have reviewed this quarterly report on Form 10-Q of Max Re Capital Ltd.;

 

2. Based on my knowledge, this report does not contain anyuntrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and otherfinancial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 

 

4. The registrant’s other certifying officers and I are responsible forestablishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: 

 

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensurethat material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

 

b) evaluated the effectiveness of the registrant’s disclosure controlsand procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based upon such evaluation; and 

 

c) disclosed in this report any change in the registrant’s internalcontrol over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materiallyaffect, the registrant’s internal control over financial reporting; and 

 

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee ofthe registrant’s board of directors (or persons performing the equivalent function): 

 

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record,process, summarize and report financial information; and 

 

b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting. 

 

Date: August 3, 2004
Exhibit 32.1



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURUSANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of Colony RIH Holdings, Inc. and Resorts International Hotel and Casino, Inc. (the Company) on Form
10-Q for the period ending September 30, 2004 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Audrey S. Oswell, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



| | 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | -- | ---------------------------------------------------------------------------------------------------------------------



| | 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                                     
|-------------------------------------
|/s/ AUDREY S. OSWELL                 
|Audrey S. Oswell                     
|President and Chief Executive Officer
|                                     
|November 12, 2004
[Federal Register Volume 89, Number 9 (Friday, January 12, 2024)]
[Notices]
[Pages 2229-2230]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-00557]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; HHS-NIH-CDC-SBIR PHS 2024-1 Phase 
I: Alternatives to Benzathine Penicillin for Treatment of Syphilis 
(Topic 134).
    Date: February 12, 2024.
    Time: 11:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3F52A 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Shilpakala Ketha, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institute of Allergy and Infectious

[[Page 2230]]

Diseases, National Institutes of Health, 5601 Fishers Lane, Room 
3F52A, Rockville, MD 20852, (301) 761-6821, <a href="/cdn-cgi/l/email-protection#fb889392978b9ad5909e8f939abb959293d59c948d"><span class="__cf_email__" data-cfemail="c3b0abaaafb3a2eda8a6b7aba283adaaabeda4acb5">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: January 9, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-00557 Filed 1-11-24; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 31.1


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

      I, Tyram H. Pettit, President, Chief Executive Officer and Chief Financial
Officer of microHelix, Inc., certify that:

      1. I have reviewed this Quarterly Report on Form 10-QSB of microHelix,
Inc.;

      2. Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this report;

      3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

      4. I am responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for
the registrant and have:

         (a) Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;

         (b) Evaluated the effectiveness of the registrant's disclosure controls
and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures as of the end of the
period covered by this report based on such evaluation; and

         (c) Disclosed in this report any change in the registrant's internal
control over financial reporting that occurred during the registrant's most
recent fiscal quarter that has materially affected, or is reasonably likely to
materially affect, the registrant's internal control over financial reporting;
and

      5. I have disclosed, based on our most recent evaluation, to the audit
committee of registrant's board of directors (or persons performing the
equivalent functions):

         (a) All significant deficiencies and material weaknesses in the design
or operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and

         (b) Any fraud, whether or not material, that involves management or
other employees who have a significant role in the registrant's internal control
over financial reporting.


Date: November 15, 2004         /s/ Tyram H. Pettit
                                ----------------------------------------------
                                Tyram H. Pettit,  President,
                                Chief Executive Officer & Chief
                                Financial Officer